Evidence map›Paper›PMID 28195477›Full record

ArticleJournal of the American Chemical Society2017

Enzymatic N- and C-Protection in Cyanobactin RiPP Natural Products.

Debosmita Sardar, Yue Hao, Zhenjian Lin, Maho Morita, Satish K Nair, Eric W Schmidt

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed.

  1. Repositioning the Leader Peptide in Graspetide Biosynthesis.Journal of the American Chemical Society · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Promiscuous Enzymes for Residue-Specific Peptide and Protein Late-Stage Functionalization.Chembiochem : a European journal of chemical biology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Biochemical characterization of a cyanobactin arginine-Chemical communications (Cambridge, England) · 2022
    Article
  11. Article
  12. Catalysts for the Enzymatic Lipidation of Peptides.Accounts of chemical research · 2022
    Review
  13. Substrate Recognition by the Peptidyl-(ACS chemical biology · 2022
    Article
  14. Bacterial terpenome.Natural product reports · 2021
    Review
  15. Article
  16. Review
  17. Review
  18. Article
  19. Algal neurotoxin biosynthesis repurposes the terpene cyclase structural fold into anProceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Debosmita SardarDepartment of Medicinal Chemistry, University of Utah , Salt Lake City, Utah 84112, United States.
Yue HaoDepartment of Biochemistry, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.
Zhenjian LinDepartment of Medicinal Chemistry, University of Utah , Salt Lake City, Utah 84112, United States.
Maho MoritaDepartment of Medicinal Chemistry, University of Utah , Salt Lake City, Utah 84112, United States.
Satish K NairDepartment of Biochemistry, University of Illinois at Urbana-Champaign , Urbana, Illinois 61801, United States.ORCID 0000-0003-1790-1334
Eric W SchmidtDepartment of Medicinal Chemistry, University of Utah , Salt Lake City, Utah 84112, United States.ORCID 0000-0001-5839-694X

Funding

Structural /Mechanistic Study of Lantibiotic Biosynthetic Enzymes & AutoimmunityR01GM079038 · NIGMS · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI NAIR, SATISH K · 2006 to 2023
$3.7M
Directed posttranslational modifications for drug design and discoveryR01GM102602 · NIGMS · UNIVERSITY OF UTAH · PI SCHMIDT, ERIC W · 2013 to 2016
$1.4M
NIGMS NIH HHS R01 GM079038NIGMS NIH HHS R01 GM102602
6 · The paper itself

Abstract

Recent innovations in peptide natural product biosynthesis reveal a surprising wealth of previously uncharacterized biochemical reactions that have potential applications in synthetic biology. Among these, the cyanobactins are noteworthy because these peptides are protected at their N- and C-termini by macrocyclization. Here, we use a novel bifunctional enzyme AgeMTPT to protect linear peptides by attaching prenyl and methyl groups at their free N- and C-termini. Using this peptide protectase in combination with other modular biosynthetic enzymes, we describe the total synthesis of the natural product aeruginosamide B and the biosynthesis of linear cyanobactin natural products. Our studies help to define the enzymatic mechanism of macrocyclization, providing evidence against the water exclusion hypothesis of transpeptidation and favoring the kinetic lability hypothesis.

Indexed as

Biological ProductsMethyltransferasesMolecular ConformationPeptide HydrolasesPeptidesTransferasesAgeMTPTBiological ProductsMethyltransferasesPeptide HydrolasesPeptidesTransferases

Identifiers

PMID28195477
PMCPMC5764894

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.